Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oakwood Labs has over two decades of experience in developing and manufacturing sustained-release injectable pharmaceuticals using its proprietary Chroniject™ platform. The company supports client projects from feasibility through commercial supply, with several products approved and marketed globally. Its most advanced programs have reached Phase III trials; five commercial products are currently manufactured at its FDA-approved facility. Internal R&D focuses on long acting injectables for CNS disorders, endocrinology, oncology, and metabolic diseases
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oakwood Labs.